Name: Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)
Price: 45724.00 ARS
Availability: InStock
Author: Office, U. S. Government Accountability
ISBN: 9781974264186

portada Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)

Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)

Formato

Libro Físico

Autor

U. S. Government Accountability Office

Editorial

Createspace

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

28.0 x 21.6 x 0.1 cm

Peso

0.09 kg.

ISBN13

9781974264186

Categorías

Métodos de investigación: general

Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)

U. S. Government Accountability Office (Autor) · Createspace · Tapa Blanda

Libro Nuevo Importado *

Envío: 17 a 23 días háb.

$ 91.448$ 45.724

-50%

* Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 45.724

Se enviará desde nuestra bodega entre el Jueves 23 de Abril y el Lunes 04 de Mayo

Más Info

Agregar a lista de deseos

Reseña del libro "Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)"

" Public health experts note the importance of providing physicians, pharmacists, and consumers with the most current prescription drug information to help inform their respective decisions on which drugs to prescribe, how best to counsel patients, and how to use drugs safely. FDA reviews manufacturer-developed drug labeling, which is generally available in paper form. However, prescription drug labeling is also publicly available in electronic form on government-operated websites. Drug manufacturers have supported eliminating paper labeling, thus relying on electronic drug labeling as a complete substitute for paper labeling. However, others, such as drug labeling manufacturers and patient advocates, disagree, suggesting that it could adversely affect public health. GAO was mandated to examine the benefits and efficiencies of electronic labeling as a partial or complete substitute and its impact on public health. Because drug labeling is already available in electronic form, representing a partial substitute, this report focuses on (1) the advantages and disadvantages of relying on electronic labeling as a complete substitute for paper labeling and (2) the barriers associated with relying on electronic labeling as a complete substitute for paper labeling. GAO interviewed federal officials, including those from FDA, and stakeholders representing physicians, pharmacies, patients, drug manufacturers, and drug labeling"

Opiniones del libro

¿Leíste este libro? Inicia sesión para poder agregar tu propia evaluación.

Ver más opiniones de clientes

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes

Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés) - Office, U. S. Government Accountability

Reseña del libro "Electronic drug labeling: no consensus on the advantages and disadvantages of its exclusive use: report to congressional committees. (en Inglés)"

Opiniones del libro

Preguntas frecuentes sobre el libro

¿El libro es original?

¿En qué Idioma está escrito el libro?

¿Cuál es la encuadernación de este libro?

Preguntas y respuestas sobre el libro

Opiniones sobre Buscalibre